- Home
- AMAL vs DNA Comparison
AMAL vs DNA Comparison
Compare AMAL & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMAL
- DNA
- Stock Information
- Founded
- AMAL 1923
- DNA 2008
- Country
- AMAL United States
- DNA United States
- Employees
- AMAL N/A
- DNA N/A
- Industry
- AMAL Commercial Banks
- DNA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AMAL Finance
- DNA Health Care
- Exchange
- AMAL Nasdaq
- DNA Nasdaq
- Market Cap
- AMAL 858.7M
- DNA 731.1M
- IPO Year
- AMAL 2018
- DNA N/A
- Fundamental
- Price
- AMAL $27.29
- DNA $14.93
- Analyst Decision
- AMAL Hold
- DNA Strong Sell
- Analyst Count
- AMAL 2
- DNA 1
- Target Price
- AMAL $33.00
- DNA $9.00
- AVG Volume (30 Days)
- AMAL 162.7K
- DNA 1.7M
- Earning Date
- AMAL 10-23-2025
- DNA 11-11-2025
- Dividend Yield
- AMAL 2.02%
- DNA N/A
- EPS Growth
- AMAL 3.73
- DNA N/A
- EPS
- AMAL 3.34
- DNA N/A
- Revenue
- AMAL $304,724,000.00
- DNA $230,815,000.00
- Revenue This Year
- AMAL $9.82
- DNA N/A
- Revenue Next Year
- AMAL $11.11
- DNA $14.41
- P/E Ratio
- AMAL $8.28
- DNA N/A
- Revenue Growth
- AMAL 4.35
- DNA 25.21
- 52 Week Low
- AMAL $25.03
- DNA $5.00
- 52 Week High
- AMAL $38.19
- DNA $16.85
- Technical
- Relative Strength Index (RSI)
- AMAL 43.85
- DNA 61.79
- Support Level
- AMAL $26.40
- DNA $10.82
- Resistance Level
- AMAL $27.79
- DNA $16.82
- Average True Range (ATR)
- AMAL 0.65
- DNA 1.11
- MACD
- AMAL 0.01
- DNA 0.40
- Stochastic Oscillator
- AMAL 41.28
- DNA 69.38
About AMAL Amalgamated Financial Corp. (DE)
Amalgamated Financial Corp is a bank holding company. It is a full-service commercial bank and a chartered trust company. It provides commercial banking and trust services nationally and offers various products and services to commercial and retail customers. It offers a complete suite of commercial and retail banking, investment management and trust and custody services.
About DNA Ginkgo Bioworks Holdings Inc.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.